Covenant Animal Health Partners takes a
species-agnostic view, aligned with industry priorities
and our technical expertise.
Contact us if you:
Have promising IP but lack the prioritized capital to pursue development.
See application in animal health for assets originally identified for the human health market.
Have a product approved for one species and initial data to support a thesis that application exists in other animal species.
Are looking for assistance with external innovation or want to expand your product portfolio without consuming internal R&D resources.